Modulation of macrophage inflammatory profile in pregnant nonobese diabetic (NOD) mice

Molecular and Cellular Endocrinology

Volumn 333, Issue 2, 2011, Pages 112-118

  Larocca, Luciana ^a   Hauk, Vanesa ^a   Calafat, Mario ^a   Roca, Valeria ^a   Fraccaroli, Laura ^a   Franchi, Ana ^b   Ramhorst, Rosanna ^a   Leirós, Claudia Pérez ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Centre de Estudios Farmacologicos y Botanicos   (Argentina)

Author keywords

Macrophage phenotypes; NOD mice; Phagocytosis; Pregnancy; VIP

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; SYNAPTOTAGMIN I; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL STIMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; FIRST TRIMESTER PREGNANCY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTE; PHAGOCYTOSIS; PHENOTYPE; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; APOPTOSIS; COCULTURE TECHNIQUES; FEMALE; INFLAMMATION; KINETICS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED NOD; NF-KAPPA B; PHAGOCYTOSIS; PREGNANCY;

EID: 79651470189     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.11.035     Document Type: Article

References (45)

1. Abumaree M.H., Stone P.R., Chamley L.W. The effects of apoptotic, deported human placental trophoblast on macrophages: possible consequences for pregnancy. J. Reprod. Immunol. 2006, 72:33-45.
2. Aisemberg J., Vercelli C., Billi S., Ribeiro M.L., Ogando D., Meiss R., McCann S.M., Rettori V., Franchi A.M. Nitric oxide mediates prostaglandins' deleterious effect on lipopolysaccharide-triggered murine fetal resorption. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:7534-7539.
3. Anderson M.S., Bluestone J.A. The NOD mouse: a model of immune dysregulation. Ann. Rev. Immunol. 2005, 23:447-485.
4. Burke S., Dong H., Hazan A.D., Croy B.A. Aberrant endometrial features of pregnancy in diabetic NOD mice. Diabetes 2007, 56:1-8.
5. Calafat M., Larocca L., Roca V., Hauk V., Pregi N., Nesse A., Pérez Leirós C Vasoactive intestinal peptide inhibits TNF-alpha-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands. Arthritis Res. Ther. 2009, 11:R53.
6. Chuang P.C., Wu M.H., Shoji Y., Tsai S.J. Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis. J. Pathol. 2009, 219:232-241.
7. Delgado M., Munoz-Elias E.J., Gomariz R.P., Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. J. Immunol. 1999, 162:1707-1716.
8. Durant S., Christeff N., Coulaud J., Nuñez E.A., Dardenne M., Homo-Delarche F. Basal concentrations of various steroids in the nonobese diabetic (NOD) mouse and effect of immobilization stress. Autoimmunity 1998, 28:249-258.
9. Ekström J. Autonomic control of salivary secretion. Proc. Finn. Dent. Soc. 1989, 85:323-331.
10. Eriksson U.J. Congenital anomalies in diabetic pregnancy. Semin. Fetal Neonatal Med. 2009, 14:85-93.
11. Evers I.M., de Valk H.W., Visser G.H. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in The Netherlands. BMJ 2004, 328:915. (published 5 April 2004). 10.1136/bmj.38043.583160.EE.
12. Fest S., Aldo P.B., Abrahams V.M., Visintin I., Alvero A., Chen R., Chavez S.L., Romero R., Mor G. Trophoblast-macrophage interactions: a regulatory network for the protection of pregnancy. Am. J. Reprod. Immunol. 2007, 57:55-66.
13. Fraccaroli L., Alfieri J., Larocca L., Calafat M., Roca V., Lombardi E., Ramhorst R., Pérez Leirós C. VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells. Br. J. Pharmacol. 2009, 156:116L 126.
14. Gomariz R.P., Arranz A., Juarranz Y., Gutierrez-Cañas I., Garcia-Gomez M., Leceta J., Martínez C. Regulation of TLR expression, a new perspective for the role of VIP in immunity. Peptides 2007, 28:1825-1832.
15. Gonzalez-Rey E., Chorny A., Delgado M. Regulation of immune tolerance by anti-inflammatory neuropeptides. Nat. Rev. Immunol. 2007, 7:52-63.
16. Gustafsson C., Mjösberg J., Matussek A., Geffers R., Matthiesen L., Berg G., Sharma S., Buer J., Ernerudh J. Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS One 2008, 3:e2078.
17. Hill J.M., Glazner G.W., Lee S.J., Gozes I., Gressens P., Brenneman D.E. Vasoactive intestinal peptide regulates embryonic growth through the action of activity-dependent neurotrophic factor. Ann. N.Y. Acad. Sci. 1999, 897:92-100.
18. Homo-Delarche F. Neuroendocrine immune-ontogeny of the pathogenesis of autoimmune diabetes in the nonobese diabetic (NOD) mouse. ILAR J. 2004, 45:237-252.
19. Huppertz B. IFPA Award in Placentology Lecture: biology of the placental syncytiotrophoblast-myths and facts. Placenta 2010, 31(Suppl.):S75-81.
20. Jimeno R., Gomariz R.P., Gutierrez-Cañas I., Martínez C., Juarranz Y., Leceta J. New insights into the role of VIP on the ratio of T-cell subsets during the development of autoimmune diabetes. Immunol. Cell Biol. 2010, 1-12. (Advance online publication, 23 March). 10.1038/icb.2010.29.
21. Jonsson M.V., Delaleu N., Brokstad K.A., Berggreen E., Skarstein K. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Arthritis Rheum. 2006, 54:2300-2305.
22. Jovanović A., Jovanović S., Tulić I., Grbović L. Predominant role for nitric oxide in the relaxation induced by vasoactive intestinal polypeptide in human uterine artery. Mol. Hum. Reprod. 1998, 4:71-76.
23. Kohmura Y., Kirikae T., Kirikae F., Nakano M., Sato I. Onapristone (ZK299) blocks the suppressive effect of progesterone, but not that of dexamethasone, on inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. Int. J. Immunopharmacol. 2000, 22:765-774.
24. Larocca L., Calafat M., Roca V., Franchi A.M., Pérez Leirós C. VIP limits LPS-induced nitric oxide production through IL-10 in NOD mice macrophages. Int. Immunopharmacol. 2007, 7:1343-1349.
25. Larocca L., Ramhorst R., Roca V., Calafat M., Aisemberg J., Franchi A., Pérez Leirós C. Neuroimmune-endocrine interactions during early pregnancy in an autoimmune context: focus on macrophage activation. Neuroimmunomodulation 2008, 15:84-90.
26. Li C., Wang W., Wang H., Zhong Y., Di J., Lin Y. Proteomic analysis of proteins differentially expressed in uterine lymphocytes obtained from wild-type and NOD mice. J. Cell. Biochem. 2009, 108:447-457.
27. Lin Y., Xu L., Jin H., Zhong Y., Di J., Lin Q.D. CXCL12 enhances exogenous CD4(+)CD25(+) T cell migration and prevents embryo loss in non-obese diabetic mice. Fertil. Steril. 2008, 91:2687-2696.
28. Mohammad M.K., Morran M., Slotterbeck B., Leaman D.W., Sun Y., Grafenstein H., Hong S.C., McInerney M.F. Dysregulated toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse. Int. Immunol. 2006, 18:1101-1113.
29. Mor G., Abrahams V.M. Potential role of macrophages as immunoregulators of pregnancy. Reprod. Biol. Endocrinol. 2003, 1:119-126.
30. Mor G., Cardenas I. The immune system in pregnancy: a unique complexity. Am. J. Reprod. Immunol. 2010, 63:425-433.
31. Mor G., Straszewski S., Kamsteeg M. Role of the Fas/Fas ligand system in female reproductive organs: survival and apoptosis. Biochem. Pharmacol. 2002, 64:1305-1315.
32. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage. Nat. Rev. Immunol. 2008, 8:958-969.
33. Nagamatsu T., Schust D.J. The contribution of macrophages to normal and pathological pregnancies. Am. J. Reprod. Immunol. 2010, 63:460-471.
34. O'Brien B.A., Huang Y., Geng X., Dutz J.P., Finegood D.T. Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 2002, 51:2481-2488.
35. Ogando D., Paz D., Cella M., Franchi A.M. The fundamental role of increased production of nitric oxide in lipopolysaccharide-induced embryonic resorption in mice. Reproduction 2003, 125:95-110.
36. Roca V., Calafat M., Larocca L., Ramhorst R., Farina M., Franchi A.M., Pérez Leirós C. Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice. Reproduction 2009, 138:733-742.
37. Roca V., Larocca L., Calafat M., Aisemberg J., Meiss R., Franchi A.M., Pérez Leirós C. Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of non-obese diabetic mice. Reproduction 2006, 132:931-938.
38. Rosignoli F., Roca V., Meiss R., Leceta J., Gomariz R.P., Pérez Leirós C. Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis. Clin. Exp. Immunol. 2005, 142:411-418.
39. Rosignoli F., Torroba M., Juarranz Y., Garcia-Gomez M., Martinez C., Gomariz R.P., Perez Leiros C., Leceta J. VIP and tolerance induction in autoimmunity. Ann. N.Y. Acad. Sci. 2006, 1070:525-530.
40. Savion S., Gidon-Dabush S., Fein A., Torchinsky A., Toder V. Diabetes teratogenicity is accompanied by alterations in macrophages and T cell subpopulations in the uterus and lymphoid organs. Int. Immunopharmacol. 2004, 4:1319-1327.
41. Soehnlein O., Lindbom L. Phagocyte partnership during the onset of inflammation. Nat. Immunol. 2010, 10:427-439.
42. Spong C.Y., Lee S.J., McCune S.K., Gibney G., Abebe D.T., Alvero R., Brenneman D.E., Hill J.M. Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide. Endocrinology 1999, 140:917-924.
43. Stoffels K., Overbergh L., Giulietti A., Kasran A., Bouillon R., Gysemans C., Mathieu C. NOD macrophages produce high levels of inflammatory cytokines upon encounter of apoptotic or necrotic cells. J. Autoimmun. 2004, 23:9-15.
44. Straszewski-Chavez S.L., Abrahams V.M., Mor G. The role of apoptosis in the regulation of trophoblast survival and differentiation during pregnancy. Endocr. Rev. 2005, 26:877-897.
45. van Blokland S.C., Versnel M.A. Pathogenesis of Sögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy. Clin. Immunol. 2002, 103:111-124.